RXI Pharma (RXII) Reports Q2 Loss of $0.11/Share
Tweet
Share
E-mailGet Alerts RXII Hot Sheet
Join SI Premium – FREE
RXI Pharma (NASDAQ: RXII) reported Q2 EPS of ($0.11), versus ($0.34) reported last year.
For earnings history and earnings-related data on RXI Pharma (RXII) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Prenetics Global (PRE) Tops Q2 EPS by 18c
- UBS Downgrades Core Natural Resources (CNR) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
